JZJian-Wei Zhu

Jian-Wei Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jian-Wei Zhu has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • MTSS1 Overexpression Correlates with Poor Prognosis in Colorectal Cancer

    by Ding Wang, Mei-Rong Xu, Tao Wang, Ting Li, Jian Wei Zhu


  • Effects of Intrahepatic Bone-Derived Mesenchymal Stem Cells Autotransplantation on the Diabetic Beagle Dogs

    by Shajun Zhu, Yuhua Lu, Jianwei Zhu, Jian Xu, Hua Huang, Mingyan Zhu, Yuquan Chen, Yuan Zhou, Xiangjun Fan, Zhiwei Wang


  • Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cells

    by Li Chen, Yuan-Yuan Wu, Peigen Liu, Jianli Wang, Guilan Wang, Jin Qin, Jiaming Zhou, Jianwei Zhu

    To investigate the effect of down-regulation of VEGF (vascular endothelial growth factor) and HPV18 E6/E7 by hairpin RNA (shRNA) on cell proliferation, apoptosis, migration, invasion, and adhesion abilities of cervical carcinoma cells, recombinant plasmids including pS-E6 shRNA, pS-E7 shRNA, and pS-VEGF shRNA were constructed and transfected into HeLa cells. The levels of E6 mRNA, E7 mRNA, or VEGF mRNA were significantly reduced after transfection of pS-E6 shRNA (76.0%), pS-E7 shRNA (74.4%), and pS-VEGF shRNA (46.7%). VEGF expression was down-regulated by pS-E6 shRNA (55.1%) and pS-E7 shRNA (46.6%). The apoptosis of HeLa cells was increased, and the proliferation, invasion, and adhesion abilities were decreased significantly. For in vivo study, cancer cells that stably expressed the plasmids were cultured. Cells were transplanted subcutaneously into nude mice to establish xenograft tumor model. Finally, expression of E6 shRNA, E7 shRNA, and VEGF shRNA in cancer cells led to inhibition of the growth of xenograft. Hence, RNA interference could effectively suppress the expression of HPV18 E6/E7 and VEGF in human cervical cancer cells. This suppression attenuates malignant biological behavior of human cervical cancer cells. RNA interference of HPV E6/E7 or VEGF expression implies an effective anti-cervical cancer strategy.


  • Open Access

    Clinicopathological Significance of Expression of Tspan-1, Jab1 and p27 in Human Hepatocellular Carcinoma

    by Li Chen, Daiyue Yuan, Gui-Lan Wang, You Wang, Yuan-Yuan Wu, Jianwei Zhu

    Chen L, et al. J Korean Med Sci. 2010 Oct;25(10):1438-1442. https://doi.org/10.3346/jkms.2010.25.10.1438


  • Open Access

    TSPAN1 protein expression: A significant prognostic indicator for patients with colorectal adenocarcinoma

    by Li Chen, Yuan-Yuan Zhu, Xiao-Juan Zhang, Gui-Lan Wang, Xin-Yu Li, Song He, Jian-Bin Zhang, Jian-Wei Zhu

    AIM: To determine if TSPAN1 overexpression is associated with clinicopathological and prognostic factors in human colorectal adenocarcinoma. METHODS: Total RNA was extracted in 20 human adenocarcinoma tissues for TSPAN1 mRNA assay by RT-PCR. Eighty-eight specimens of human colorectal adenocarcinoma were surgically removed. TSPAN1 protein levels in cancer tissues were determined by immunohistochemistry using a polyclonal antibody against self-prepared TSPAN1. The correlation between TSPAN1 expression and the clinicopathological factors and the overall survival rate was analyzed by univariate and multivariate assay. RESULTS: TSPAN1 mRNA was detected in 90.0% (18/20) of cancerous tissues. The light density of TSPAN1 mRNA expression levels was 0.89 ± 0.30 in adenocarcinoma by gel-image system. TSPAN1 protein expression was detected in 78.41% (69/88) and weakly expressed in 40% normal colorectal tissues. There were significant differences between colorectal adenocarcinoma and normal control epithelium (P < 0.05). TSPAN1 protein expression in colorectal cancerous tissue was significantly correlated with the histological grade, cell expression PCNA, lymph nodal metastasis and TNM staging of the disease. Patients with TSPAN1 protein overexpression had a significantly shorter survival period than that in patients with TSPAN1 protein negative or weak expression, respectively (P < 0.05). Furthermore, by multivariate analysis, TSPAN1 protein expression demonstrated an independent prognostic factor for human colorectal cancers (P < 0.05, relative risk 0.755; 95% confidence interval 0.302-1.208). CONCLUSION: The expression of TSPAN1 gene is increased in colorectal carcinoma, suggesting that TSPAN1 might serve as an independent prognostic factor for the colorectal adenocarcinoma patients.


  • Open Access

    Inhibition of spreading, migration and invasion of colon cancer cells by Cortactin small RNA interference

    by Jian-Wei Zhu, Ren Zhao

    目的: 研究Cortactin对大肠癌细胞运动性和侵袭力的影响. 方法: HT-29细胞常规培养, 在体外合成Cortactin siRNA后转染结肠癌细胞, 通过Western blot和免疫荧光观察转染后Cortactin表达量变化, 通过癌细胞体外迁移侵袭实验和伸展实验来观察转染后癌细胞伸展、迁移和侵袭能力的改变. 结果: Western blot和免疫荧光显示Cortactin在siRNA处理后癌细胞内的表达水平明显下降; 癌细胞经过Cortactin siRNA处理后细胞的胞膜展开比对照组晚; Cortactin siRNA处理的大肠癌细胞和对照GFP siRNA处理的癌细胞通过涂胶基膜和微孔的细胞数目统计分别为60±15个和340±45个, 两者差异有统计学意义(P结论: Cortactin可能对大肠癌的侵袭转移发挥作用.

  • Open Access

    Interference targeting the G-actin binding domain of N-WASP inhibits the invasion and metastasis of colon cancer cells

    by Bao-Yu Huang, Ren Zhao, Jing Qin, Xiao-Bin Jia, Jian-Wei Zhu

    目的: 探讨干扰N-WASP功能区对大肠癌细胞侵袭转移能力的影响. 方法: 采用基因克隆方法构建包含N-WASP功能区V片段的重组质粒, 转染大肠癌株LoVo. 采用Transwell穿膜实验观察大肠癌细胞侵袭能力的变化; 应用Capture-ELISA方法检测大肠癌细胞内吞生物素标记的转铁蛋白(Tfn)的能力改变. 脾内注射制备大肠癌肝转移裸鼠模型, 在体内进一步观察大肠癌细胞转移能力改变. 结果: 成功构建了含有N-WASP的V结构区域的重组质粒, 并转染大肠癌株LoVo获得稳定表达. 实验组表达V片段的大肠癌细胞穿膜的细胞数为42.15±7.35, 而对照表达空载体的大肠癌细胞穿膜细胞数为85.25±6.16, 未转染的大肠癌细胞穿膜细胞数为84.35±7.99, 与实验组相比具有显著差异(P结论: 靶向干预N-WASP与微丝蛋白结合的功能区域的新方法能够抑制人大肠癌细胞的侵袭和转移能力.

    • 1 December 2007
      • Vol. 29  (12) , 917-21

    [Expression and significance of NET-1 protein in hepatocellular carcinoma].

    by Li Chen, Xing-Yu Li, You Wang, Yuan-Yuan Zhu, Jian-Wei Zhu

    This study was designed to investigate the expression and significance of NET-1 in hepatocellular carcinoma (HCC) and analyze the relationship between NET-1 gene expression and clinicopathologic factors in HCC. NET-1 gene protein expression was detected by Western blot, fluorescence immunocytochemistry, confocal laser scanning microscopy and immunohistochemistry in 8 cases of HCC tissues, human hepatoma cell line SMMC-7721, and paraffin-embeded sections from 130 cases of HCC. NET-1 gene protein expressed in 8 cases of HCC tissues by Western blot. The NET-1 gene protein positively located in the cytoplasm as irregular granules near Golgi apparatus in SMMC-7721cells, detected by fluorescent immunocytochemistry and observed by confocal laser scanning microscopy. The positive rate of NET-1 protein expression revealed by immunohistochemistry was 96.9% in HCC (126/130). NET-1 Protein expression in HCC was clearly correlative with HCC cytological variants, there were pronounced higher expressions in clear cell type, pleomorphic cell type, and sarcomatous change than that in hepatocytic type (P < 0.05). NET-1 Protein expression in HCC was positively correlative with the histopathologic grading, clinical stages and HCC with hepatitis and cirrhosis (P < 0.05), respectively, and negatively correlated with the presence of patches of necrosis (P < 0.05). But NET-1 protein expression was not associated with AFP level, tumor size and growth patterns, respectively. NET-1 protein is expressed in cytoplasm of HCC cells as irregular granules near Golgi apparatus. NET-1 gene expression may promote the uncontrolled proliferation and abnormal differentiation in HCC cells.


  • Association of NET-1 Gene Expression With Human Hepatocellular Carcinoma

    by Li Chen, Zhiwei Wang, Xi Zhan, De-Chuen Li, York-Yuan Zhu, Jianwei Zhu

    NET-1 is a member of the NET-x family. To explore the potential role of NET-1 in hepatocellular carcinoma (HCC), the expression of NET-1 and the relationship with HCC were examined for the first time. We found that NET-1 was frequently expressed in HCC and the peritumor tissue. The relative amounts of NET-1 mRNA in HCC and peritumor tissue were 0.645 ± 0.37 and 0.466 ± 0.30, respectively, indicating a higher expression level in HCC than in the peritumor (P < .05). NET-1 protein is usually located on the cell membrane and in the cytoplasm of HCC cells. NET-1 immunoreactivity was found in 126 out of 130 samples of HCC tissue (96.92%). An association of NET-1 expression with cytological variants, histopathological grading, and clinical stages of HCC was also found (P < .05). Detection of NET-1 gene expression in liver biopsy may provide useful information about the biological behavior of HCC.